Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs is a research paper published in JAMA Network Open (2021). On theSindex it has a DataRank of 0. It has been cited 57 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR001863
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 5K01AA028258-04
Identifying patient subgroups that are most likely to benefit from medications used to treat alcohol use disorder
FWCI
8.39
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals